BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9473776)

  • 1. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Cermák J; Roubková H
    Neoplasma; 1996; 43(3):171-8. PubMed ID: 8841504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cathepsin B activity by cysteine and related thiols.
    Krepela E; Procházka J; Kárová B
    Biol Chem; 1999 May; 380(5):541-51. PubMed ID: 10384960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
    Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
    Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cathepsin B activity in human lung tumors.
    Krepela E; Kasafírek E; Novák K; Viklický J
    Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple forms of cathepsin B in human lung cancer.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Polák J; Cermák J; Roubková H
    Int J Cancer; 1995 Mar; 61(1):44-53. PubMed ID: 7705933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
    Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B and cysteine protease inhibitors in human osteoarthritis.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Orthop Res; 1990 May; 8(3):336-44. PubMed ID: 2324852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of increased lung tumor tissue cathepsin B.
    Ebert W; Knoch H; Werle B; Trefz G; Muley T; Spiess E
    Anticancer Res; 1994; 14(3A):895-9. PubMed ID: 8074490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer.
    Gasinska A; Kolodziejski L; Niemiec J; Dyczek S
    Lung Cancer; 2005 Aug; 49(2):171-9. PubMed ID: 16022910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.
    Zore I; Krasovec M; Cimerman N; Kuhelj R; Werle B; Nielsen HJ; Brünner N; Kos J
    Biol Chem; 2001 May; 382(5):805-10. PubMed ID: 11517934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cys-His proteases are among the wired proteins of the cell.
    Lockwood TD
    Arch Biochem Biophys; 2004 Dec; 432(1):12-24. PubMed ID: 15519292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
    Downs LS; Lima PH; Bliss RL; Blomquist CH
    J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of some lysosomal enzymes in serum and in tumors of patients with squamous cell lung carcinoma.
    Woźniak A; Drewa T; Rozwodowska M; Drewa G; Lambrecht W; Wiśniewska I
    Neoplasma; 2002; 49(1):10-5. PubMed ID: 12044053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
    Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence demonstration of cathepsin B-like cysteine proteinase activity in lung squamous cell carcinomas and surrounding tissues.
    Kolár Z
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():203-9. PubMed ID: 2946180
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
    Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.